Financial Ratios

TEJNAKSH HEALTHCARE LTD.

NSE : NABSE : 539428ISIN CODE : INE030T01027Industry : Hospital & Healthcare ServicesHouse : Private
BSE25.110.07 (+0.28 %)
PREV CLOSE ( ) 25.04
OPEN PRICE ( ) 25.57
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20286
TODAY'S LOW / HIGH ( )24.72 25.60
52 WK LOW / HIGH ( ) 22.5537.24
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.362.481.971.892.65
   CEPS(Rs)1.071.531.291.241.58
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)20.6219.2516.7614.7812.89
   Tax Rate(%)29.7025.2722.6227.7028.21
Margin Ratios
   Core EBITDA Margin(%)42.7653.0941.8930.9525.90
   EBIT Margin(%)35.2047.4336.5330.0632.36
   Pre Tax Margin(%)26.7641.5230.2723.1426.87
   PAT Margin (%)18.8131.0323.4216.7319.29
   Cash Profit Margin (%)29.5938.3230.5721.8323.04
Performance Ratios
   ROA(%)4.729.598.328.4213.27
   ROE(%)6.8113.7712.5113.6922.93
   ROCE(%)9.5715.8714.1416.5824.12
   Asset Turnover(x)0.250.310.360.500.69
   Sales/Fixed Asset(x)0.350.490.500.650.87
   Working Capital/Sales(x)2.063.8811.402.688.05
Efficiency Ratios
   Fixed Capital/Sales(x)2.892.042.011.531.15
   Receivable days43.5318.4319.1411.925.78
   Inventory Days20.5120.3115.9912.669.36
   Payable days91.1680.98172.47160.07204.21
Valuation Parameters
   PER(x)25.3633.9736.8919.0120.98
   PCE(x)32.2555.0228.2614.5717.56
   Price/Book(x)3.348.754.342.444.31
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)10.0821.659.153.724.43
   EV/Core EBITDA(x)21.9339.5620.9510.5912.27
   EV/EBIT(x)28.6445.6425.0512.3813.69
   EV/CE(x)2.486.133.281.762.89
   M Cap / Sales9.5421.088.643.184.05
Growth Ratio
   Net Sales Growth(%)-9.64-5.14-25.57-17.6361.88
   Core EBITDA Growth(%)-24.0918.83-7.51-19.817.63
   EBIT Growth(%)-32.9423.16-9.53-23.496.35
   PAT Growth(%)-45.2225.684.19-28.5510.76
   EPS Growth(%)-45.2225.674.20-28.55-75.92
Financial Stability Ratios
   Total Debt/Equity(x)0.310.360.290.480.48
   Current Ratio(x)3.852.121.543.951.90
   Quick Ratio(x)3.581.861.243.721.66
   Interest Cover(x)4.178.025.834.355.89
   Total Debt/Mcap(x)0.090.040.070.200.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.